title: [Hereditary angioneurotic edema. Recent progress in diagnosis and treatment. Importance of a national registry].
abstract: The hereditary angioneurotic oedema is an exceptional disease of deadly risk from glottic oedema. The diagnosis is based on a very low serum C4, with collapsed C1 INH for a patient who has repeated attacks of Quincke's oedema or pseudo occlusive digestive crisis. These crisis are prevented by taking anabolic steroids and must be treated when they are serious by intravenous C1 INH. The recent contributions of the immunogenetic and the interest of a national registry are underlined.
authors.affiliation: Service de Néphrologie, Hôpital Henri Mondor, Creteil.
authors.forename: J
authors.initials: J
authors.lastname: Laurent
authors.forename: G
authors.initials: G
authors.lastname: Lagrue
mesh_terms: D000799:Angioedema / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency / Q000235:genetics; D003181:Complement C4 / Q000172:deficiency; D003613:Danazol / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005602:France / Q000453:epidemiology; D005799:Genes, Dominant; D006801:Humans; D009645:Norgestrienone / Q000627:therapeutic use; D012042:Registries
chemical_list: D003174:Complement C1 Inactivator Proteins; D003181:Complement C4; D005343:Fibrinolytic Agents; D009645:Norgestrienone; D003613:Danazol